We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Prediction of Adverse Perinatal Outcome for Preeclampsia in Sichuan Province of China

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01804751
Recruitment Status : Unknown
Verified June 2013 by Xinghui Liu, West China Second University Hospital.
Recruitment status was:  Not yet recruiting
First Posted : March 5, 2013
Last Update Posted : August 25, 2015
Sichuan Academy of Medical Sciences
people's hospital of Guang'an
The first people's hospital of Neijiang
Suining Central Hospital
Sichuan Provincial Maternal and Child Health Care Hospital
Chengdu Women's and Children's Central Hospital
Luzhou Medical College
pengzhou shi fuyou baojianyuan
Nanchong Central Hospital
Information provided by (Responsible Party):
Xinghui Liu, West China Second University Hospital

Brief Summary:
The purpose of this study is to build a model for the prediction of adverse perinatal outcome for preeclampsia in china

Condition or disease

Study Type : Observational
Observational Model: Cohort
Time Perspective: Prospective
Study Start Date : January 2016
Estimated Primary Completion Date : December 2016

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Primary Outcome Measures :
  1. maternal mortality [ Time Frame: within 48h of eligibility ]

Secondary Outcome Measures :
  1. serious central nervous system morbidity [ Time Frame: within 48h of eligibility ]
  2. serious cardiorespiratory morbidity [ Time Frame: within 48h of eligibility ]
  3. serious hepatic morbidity. [ Time Frame: within 48h of eligibility ]
  4. serious renal morbidity [ Time Frame: within 48h of eligibility ]
  5. serious haematological morbidity [ Time Frame: within 48h of eligibility ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Chinese women who fulfilled a research definition of preeclampsia, and who were admitted to participating obstetric centres

Inclusion Criteria:

  • admitted with preeclampsia or had developed preeclampsia after admission

Exclusion Criteria:

  • admitted in spontaneous labour or had achieved any component of the maternal outcome before either fulfilling eligibility criteria or collection of predictor data

Responsible Party: Xinghui Liu, professor, West China Second University Hospital
ClinicalTrials.gov Identifier: NCT01804751     History of Changes
Other Study ID Numbers: hx2ck2
First Posted: March 5, 2013    Key Record Dates
Last Update Posted: August 25, 2015
Last Verified: June 2013

Additional relevant MeSH terms:
Hypertension, Pregnancy-Induced
Pregnancy Complications